368 related articles for article (PubMed ID: 28869604)
41. Long non-coding RNA AK058003, as a precursor of miR-15a, interacts with HuR to inhibit the expression of γ-synuclein in hepatocellular carcinoma cells.
He X; Zheng Y; Zhang Y; Gan Y; Zhou Y; Liang H; Wu D; Ge W; Deng J; Xu X
Oncotarget; 2017 Feb; 8(6):9451-9465. PubMed ID: 28035067
[TBL] [Abstract][Full Text] [Related]
42. Long noncoding RNA MINCR regulates cellular proliferation, migration, and invasion in hepatocellular carcinoma.
Cao J; Zhang D; Zeng L; Liu F
Biomed Pharmacother; 2018 Jun; 102():102-106. PubMed ID: 29550632
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
44. Noncoding RNA as therapeutic targets for hepatocellular carcinoma.
George J; Patel T
Semin Liver Dis; 2015 Feb; 35(1):63-74. PubMed ID: 25632936
[TBL] [Abstract][Full Text] [Related]
45. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
[TBL] [Abstract][Full Text] [Related]
46. miRNA-370 acts as a tumor suppressor via the downregulation of PIM1 in hepatocellular carcinoma.
Pan XP; Wang HX; Tong DM; Li Y; Huang LH; Wang C
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1254-1263. PubMed ID: 28387905
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X
Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017
[TBL] [Abstract][Full Text] [Related]
48. Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.
Müller S; Raulefs S; Bruns P; Afonso-Grunz F; Plötner A; Thermann R; Jäger C; Schlitter AM; Kong B; Regel I; Roth WK; Rotter B; Hoffmeier K; Kahl G; Koch I; Theis FJ; Kleeff J; Winter P; Michalski CW
Mol Cancer; 2015 Apr; 14():94. PubMed ID: 25910082
[TBL] [Abstract][Full Text] [Related]
49. Astragaloside IV inhibits cell migration and viability of hepatocellular carcinoma cells via suppressing long noncoding RNA ATB.
Li Y; Ye Y; Chen H
Biomed Pharmacother; 2018 Mar; 99():134-141. PubMed ID: 29331759
[TBL] [Abstract][Full Text] [Related]
50. Noncoding RNAs in liver cancer stem cells: The big impact of little things.
Lv H; Lv G; Han Q; Yang W; Wang H
Cancer Lett; 2018 Apr; 418():51-63. PubMed ID: 29307614
[TBL] [Abstract][Full Text] [Related]
51. Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells.
Yin X; Zheng SS; Zhang L; Xie XY; Wang Y; Zhang BH; Wu W; Qiu S; Ren ZG
Gene; 2017 Jan; 596():53-88. PubMed ID: 27729273
[TBL] [Abstract][Full Text] [Related]
52. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).
Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
Int J Clin Exp Pathol; 2015; 8(1):337-44. PubMed ID: 25755720
[TBL] [Abstract][Full Text] [Related]
54. The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a.
Youness RA; Hafez HM; Khallaf E; Assal RA; Abdel Motaal A; Gad MZ
J Cell Physiol; 2019 Nov; 234(11):20286-20297. PubMed ID: 30968427
[TBL] [Abstract][Full Text] [Related]
55. Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma.
Gao Y; Chen G; Zeng Y; Zeng J; Lin M; Liu X; Liu J
Tumour Biol; 2015 Sep; 36(10):7409-22. PubMed ID: 25900874
[TBL] [Abstract][Full Text] [Related]
56. Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway.
Peng W; Fan H
Biomed Pharmacother; 2016 Oct; 83():450-455. PubMed ID: 27427851
[TBL] [Abstract][Full Text] [Related]
57. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
[TBL] [Abstract][Full Text] [Related]
58. The tumor-suppressive miR-497-195 cluster targets multiple cell-cycle regulators in hepatocellular carcinoma.
Furuta M; Kozaki K; Tanimoto K; Tanaka S; Arii S; Shimamura T; Niida A; Miyano S; Inazawa J
PLoS One; 2013; 8(3):e60155. PubMed ID: 23544130
[TBL] [Abstract][Full Text] [Related]
59. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression.
Chang S; Chen B; Wang X; Wu K; Sun Y
BMC Cancer; 2017 Apr; 17(1):248. PubMed ID: 28388883
[TBL] [Abstract][Full Text] [Related]
60. Identification of novel biomarkers for hepatocellular carcinoma using transcriptome analysis.
Xia Q; Li Z; Zheng J; Zhang X; Di Y; Ding J; Yu D; Yan L; Shen L; Yan D; Jia N; Chen W; Feng Y; Wang J
J Cell Physiol; 2019 Apr; 234(4):4851-4863. PubMed ID: 30272824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
